Skip to main content
OpenTrials
Completed

NCT Number: NCT04821466

VR for Symptom Control and Wellbeing

To investigate the effect that a Virtual Reality experience can have on patient symptoms and wellbeing for palliative care and oncology inpatients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Oncology End Stage Cancer Hematologic Diseases Hematologic Malignancy Hematologic Neoplasms Hemic and Lymphatic Diseases Neoplasms Neoplasms by Site Palliative Care

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Royal Cornwall Hospital

Truro, Cornwall, TR1 3HD, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • > 18 years of age
  • Inpatient at RCHT know to the palliative care team
  • Able to consent
  • Able to speak and understand the English language
  • Able to use the virtual reality system
  • Able to complete ESAS-r Questionnaire

Exclusion criteria

  • <18 years of age
  • Patient unable to consent
  • Patient unable to speak English
  • Unable to use the virtual reality system (e.g. visually impaired)
  • Known Epilepsy or seizures or suspected predisposition to seizures (e.g. Brain metastasis)

Treatment and study plan

Virtual Reality Headset to provide a Virtual Reality Experience

Device

Participants will utilise a Virtual Reality experience for distraction therapy via a Virtual reality headset. Participants will wear the Virtual reality headset to be immersed in a multimedia experience.

Primary outcomes

  1. ESAS-r Quality of Life Scores

    Time frame: Time 0 & Time 60 minutes

    Change in ESAS-r QoL score between start and finish of Virtual Reality experience. 0 = No symptoms to 10 = Worst Symptom

Secondary outcomes

  1. Quantitative clinician experience of VR intervention

    Time frame: Time 60 minutes

    Clinician score of patient experience using Virtual Reality intervention for symptoms and wellbeing between 0 (negative) and 10 (positive)

  2. Quantitative clinician experience of VR intervention

    Time frame: Time 60 minutes

    Patient score of experience using Virtual Reality intervention for symptoms and wellbeing between 0 (negative) and 10 (positive)

Other outcomes

  1. Qualitative patient experience of VR interventions

    Time frame: Time 60 minutes

    Patients to answer: Were there any negative side effects of the VR session?

  2. Repeat VR experiences

    Time frame: 12 Months

    ESAS-r QoL Scores (0 to 10) will be collected each time a patient uses the experience to consider the effect repeat exposure has on wellbeing and symptoms. 0 = No symptoms to 10 = Worst Symptom

Sponsors and collaborators

Lead sponsor

Royal Cornwall Hospitals Trust

Other

Registry information

Official study title

The Use of Virtual Reality for Symptom Control and Wellbeing in Palliative Care and Oncology Patients

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Mar 29, 2021
Registry last updated
Nov 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.